HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Business Strategies M & A Consumer

J&J Rides Standalone Consumer Health Track

  • Analysis

Executive Summary

J&J takes same approach GSK, Pfizer, Merck & Co, Merck and Novartis have with their consumer health businesses, Bausch Health is starting and Sanofi says it will.

You may also be interested in...



Consumer Health Changes ‘At Speed Of Instagram’ Drive J&J’s Decision On Separating Businesses

J&J provided color on plans for standalone consumer health business during a business overview with analysts. Multiple separation pathways are being considered.

Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation

Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.

McNamara To Lead GSK’s Standalone Consumer Healthcare Business

Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.

Table

View full table

Related Content

HBW Insight
HBW Insight
HBW Insight
HBW Insight
Pink Sheet
Pink Sheet
HBW Insight

Topics

Related Companies

Tags:
Business Strategies M & A Consumer
UsernamePublicRestriction

Register

RS151944

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By